<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Lamotrigine: epilepsy" /><meta name="IX" content="Lamotrigine: epilepsy" /><title>Lamotrigine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="129256.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="129256.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=129256.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3574.htm">4.8 Antiepileptic drugs</a> &gt; <a href="3575.htm">4.8.1 Control of the epilepsies</a> &gt; <a href="9827.htm">Lamotrigine</a> &gt; <a href="9832.htm">LAMOTRIGINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="9827.htm" title="Previous: Lamotrigine">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="89415.htm" title="Next: Levetiracetam">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a395007.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Anticonvulsants, Miscellaneous 28:12.92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/18658-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Lamotrigine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: L &gt; Interactions of Lamotrigine</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="9805.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Focal seizures with or without secondary generalisation</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="9808.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Generalised seizures</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="202444.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Epilepsy syndromes</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22lamotrigine%22%22lamotrigine%22%22lamotrigine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (6)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/9805.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Focal seizures with or without secondary generalisation</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/9808.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Generalised seizures</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/9827.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22lamotrigine%22%22lamotrigine%22%22lamotrigine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e622261.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0011s0018.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; L</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/18658-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05353.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; L &gt; LA</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D158.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Lamotrigine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c210.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamotrigine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; L</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_9832">LAMOTRIGINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i283.htm" title="Go to appendix 1">Lamotrigine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">monotherapy and adjunctive treatment of focal
seizures and generalised seizures including tonic-clonic seizures;
seizures associated with Lennox-Gastaut syndrome; monotherapy of typical
absence seizures in children; prevention of depressive episodes associated
with bipolar disorder</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">closely monitor and consider withdrawal
if rash, fever, or other signs of hypersensitivity syndrome develop; avoid abrupt withdrawal (taper off over 2 weeks or
longer) unless serious skin reaction occurs; myoclonic seizures (may be exacerbated); Parkinson’s disease (may be exacerbated); <b>interactions:</b> see <a title="target-block: Interactions in epilepsy" href="3575.htm#_120547">Interactions</a> in section 4.8.1 and Appendix 1 (<span>lamotrigine</span>)</p><div class="cAV"><h3>Blood disorders</h3> <p class="cAX">Patients and their
carers should be alert for symptoms and signs suggestive of bone-marrow
failure, such as anaemia, bruising, or infection. Aplastic
anaemia, bone-marrow depression, and pancytopenia have been associated
rarely with <span>lamotrigine</span></p></div></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">halve dose in moderate impairment; quarter dose in
severe impairment</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">caution in renal failure; metabolite may accumulate;
consider reducing maintenance dose in significant impairment</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="3575.htm#_120546">Pregnancy</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:target-block: breast-feeding control of epilepsy" href="3575.htm#_207526">Breast-feeding</a></p></div><div class="cAF" id="_200955"><h2>Side-effects</h2> <p class="cAF">nausea, vomiting, diarrhoea, dry mouth, aggression,
agitation, headache, drowsiness, dizziness, tremor, insomnia, ataxia,
back pain, arthralgia, nystagmus, diplopia, blurred vision, rash (see
Skin Reactions, below); <i>rarely</i> conjunctivitis; <i>very rarely</i> hepatic failure, movement disorders, unsteadiness,
increase in seizure frequency, exacerbation of Parkinson’s disease,
confusion, hallucination, blood disorders (including anaemia, leucopenia,
thrombocytopenia, pancytopenia—see Blood Disorders, above), hypersensitivity
syndrome (see <a title="BNF:target-block: antiepileptic hypersensitivity syndrome" href="3575.htm#_219197">Antiepileptic Hypersensitivity
Syndrome</a>),
lupus erythematosus-like reactions; <i>also reported</i> suicidal ideation, aspectic meningitis</p><div class="cAV"><h3>Skin reactions</h3> <p class="cAX">Serious skin reactions including
Stevens-Johnson syndrome and toxic epidermal necrolysis have developed
(especially in children); most rashes occur in the first 8 weeks.
Rash is sometimes associated with hypersensitivity syndrome (see Side-effects,
above) and is more common in patients with history of allergy or rash
from other antiepileptic drugs. Consider withdrawal if rash or signs
of hypersensitivity syndrome develop. Factors associated
with increased risk of serious skin reactions include concomitant
use of valproate, initial <span>lamotrigine</span> dosing higher
than recommended, and more rapid dose escalation than recommended.</p></div><div class="cAV"><h3>Counselling</h3> <p class="cAX">Warn patients to see
their doctor immediately if rash or signs or symptoms of hypersensitivity
syndrome develop (see <a title="BNF:target-block: antiepileptic hypersensitivity syndrome" href="3575.htm#_219197">Antiepileptic Hypersensitivity
Syndrome</a>)</p></div></div><div class="cAF"><h2>Dose</h2> <div class="cAT"><h3>Important</h3> <p class="cAX">Do not confuse the different combinations
or indications; see also notes above</p></div><div class="cAT"><h3>Note</h3> <p class="cAX">Dose titration should be repeated if restarting
after an interval of more than 5 days</p></div><p class="cR">Monotherapy of seizures, <span class="cAK">adult</span> and <span class="cAK">child</span> over 12 years, initially
25 mg once daily for 14 days, increased to 50 mg once daily for further
14 days, then increased by max. 100 mg every 7–14 days; usual maintenance
100–200 mg daily in 1–2 divided doses (up to 500 mg daily has been
required)</p><p class="cR">Monotherapy of typical absence seizures, <span class="cAK">child</span> 2–12 years see <a href="http://www.medicinescomplete.com/mc/bnfc/current/9832.htm" title="BNFC:monograph: LAMOTRIGINE"><i>BNF for Children</i></a></p><p class="cR">Adjunctive therapy of seizures <i>with valproate</i>, <span class="cAK">adult</span> and <span class="cAK">child</span> over 12 years, initially 25 mg on alternate days for 14 days then
25 mg once daily for further 14 days, thereafter increased by max.
50 mg every 7–14 days; usual maintenance, 100–200 mg daily in 1–2
divided doses; <span class="cAK">child</span> 2–12 years initially
150 micrograms/kg once daily for 14 days (those weighing under 13 kg
may receive 2 mg on alternate days for first 14 days) then 300 micrograms/kg
once daily for further 14 days, thereafter increased by max. 300 micrograms/kg
every 7–14 days; usual maintenance 1–5 mg/kg daily in 1–2 divided
doses; max. 200 mg daily</p><p class="cR">Adjunctive therapy of seizures (with enzyme inducing drugs) <i>without valproate</i>, <span class="cAK">adult</span> and <span class="cAK">child</span> over 12 years, initially 50 mg once daily for
14 days then 50 mg twice daily for further 14 days, thereafter increased
by max. 100 mg every 7–14 days; usual maintenance 200–400 mg daily
in 2 divided doses (up to 700 mg daily has been required); <span class="cAK">child</span> 2–12 years initially 600 micrograms/kg daily
in 2 divided doses for 14 days then 1.2 mg/kg daily in 2 divided doses
for further 14 days, thereafter increased by max. 1.2 mg/kg every
7–14 days; usual maintenance 5–15 mg/kg daily in 1–2 divided doses;
max. 400 mg daily</p><p class="cR">Adjunctive therapy of seizures (without enzyme inducing drugs) <i>without valproate</i>, <span class="cAK">adult</span> and <span class="cAK">child</span> over 12 years, initially 25 mg once daily for
14 days, increased to 50 mg once daily for further 14 days, then increased
by max. 100 mg every 7–14 days; usual maintenance 100–200 mg daily
in 1–2 divided doses; <span class="cAK">child</span> 2–12 years
initially 300 micrograms/kg daily in 1–2 divided doses for 14 days
then 600 micrograms/kg daily in 1–2 divided doses for further 14 days,
thereafter increased by max. 600 micrograms/kg every 7–14 days; usual
maintenance 1–10 mg/kg daily in 1–2 divided doses; max. 200 mg daily</p><p class="cR">Monotherapy <i>or </i>adjunctive therapy of bipolar
disorder (without enzyme inducing drugs) <i>without valproate</i>, <span class="cAK">adult</span> over 18 years, initially 25 mg
once daily for 14 days, then 50 mg daily in 1–2 divided doses for
further 14 days, then 100 mg daily in 1–2 divided doses for further
7 days; usual maintenance 200 mg daily in 1–2 divided doses; max.
400 mg daily</p><p class="cR">Adjunctive therapy of bipolar disorder <i>with valproate</i>, <span class="cAK">adult</span> over 18 years, initially 25 mg
on alternate days for 14 days, then 25 mg once daily for further 14
days, then 50 mg daily in 1–2 divided doses for further 7 days; usual
maintenance 100 mg daily in 1–2 divided doses; max. 200 mg daily</p><p class="cR">Adjunctive therapy of bipolar disorder (with enzyme inducing
drugs) <i>without valproate</i>, <span class="cAK">adult</span> over 18 years, initially 50 mg once daily for 14 days, then 50 mg
twice daily for further 14 days, then 100 mg twice daily for further
7 days, then 150 mg twice daily for further 7 days; usual maintenance
200 mg twice daily</p><div class="cAR"><h3>Note</h3> <p class="cAX">Patients stabilised on lamotrigine for bipolar
disorder may require dose adjustments if other drugs are added to
or withdrawn from their treatment regimens—consult product literature</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_129256" style="margin: 0 0 0 20px;"><h1 class="title">Lamotrigine<span> (Non-proprietary)</span> <a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_s.png" alt="Black triangle" /></a> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Tablets</span>, lamotrigine 25 mg, net
price 56-tab pack = £2.06; 50 mg, 56-tab pack = £2.76; 100 mg, 56-tab
pack = £4.00; 200 mg, 30-tab pack = £27.53, 56-tab pack = £6.63. 
    Label:
    8, counselling, driving (see <a title="target-block: Driving and epilepsy" href="3575.htm#_200951">notes above</a>), skin reactions (see <a title="target-block: lamotrigine disorders" href="9832.htm#_200955">above</a>)</div><div class="cAY"><span class="cAB">Dispersible tablets</span>, lamotrigine
5 mg, net price 28-tab pack = £2.10; 25 mg, 56-tab pack = £2.87; 100 mg,
56-tab pack = £5.13. 
    Label:
    8, 13, counselling, driving (see <a title="target-block: Driving and epilepsy" href="3575.htm#_200951">notes above</a>), skin reactions (see <a title="target-block: lamotrigine disorders" href="9832.htm#_200955">above</a>)</div></li><li><a href="9833.htm#_9833" title="Lamictal®">Lamictal®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="9827.htm">Previous: Lamotrigine</a> | <a class="top" href="129256.htm#">Top</a> | <a accesskey="]" href="89415.htm">Next: Levetiracetam</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>